Accounts Payable and Accrued Expenses

3 Months Ended

Mar. 31, 2025

5. Accounts Payable and Accrued Expenses:

Accounts payable and accrued expenses consist of the following (in thousands):


	March 31, 2025		December 31, 2024
Accounts payable	$	44,120	$	46,431
Accrued salaries and incentive compensation		74,099		215,357
Accrued payroll taxes and benefits		25,375		35,450
Accrued professional liabilities		29,968		30,430
Accrued interest		2,782		8,159
Other accrued expenses		57,829		62,863
	$	234,173	$	398,690

The net decrease in accrued salaries and incentive compensation of $141.3 million, from December 31, 2024 to March 31, 2025, is primarily due to the payment of performance-based incentive compensation, principally to the Company’s affiliated physicians, partially offset by performance-based incentive compensation accrued during the three months ended March 31, 2025. A majority of the Company’s payments for performance-based incentive compensation is paid annually during the first quarter.